- One company is a Danish food-tech company for which Pre-IPO funding of 2,5mDKK was raised from a group of private investors. The company is well underway in it’s international roll-out and aims for global leadership in its field.
- The other company is a Swedish pharma company for which Pre IPO funding of 15mSEK was raised from group of private investors. The company has developed a unique technology platform that delivers on a promise to address major women’s health issues in a global scale.
This last case also marks Gemstone Capital’s second biotech case and its first pure Swedish case, served by Gemstone and its investor network in Sweden and Denmark.
Please contact Peter Max at email@example.com or +45 24242600 if you wish to hear more about these opportunities, including the potential opportunity to participate in IPO pre-subscription in due time.